The healthcare sector enjoyed a positive year in 2011 despite volatility in overall markets. This is because the sector is often perceived as more defensive no matter uncertainties surrounding government healthcare changes and mandates.
There is a lot to choose from in terms of indexes linked to ETFs. Some indexes are passive and duplicative relatively while some are "enhanced" making them quasi-active. The latter apply quantitative analytical techniques and skills to provide outperformance. Investors should note that in a rising market, particularly ETFs linked to enhanced issues will tend to outperform conventional index linked issues.
New ETFs from highly regarded and substantial new providers are also being issued. These may include Charles Schwab's ETFs and Scottrade's Focus Shares which both are issuing new ETFs with low expense ratios and commission free trading at their respective firms. These may also become popular as they become seasoned.
Using our long experience as an ETF publication, and nearly 40 years in the investment business, we can help select those ETFs that matter and may or may not be repetitive. The result is a more manageable list of issues from which to view and make selections. There is currently an expanding list of 24 ETFs oriented to the healthcare sector with more on the way. The following analysis features a fair representation of ETFs available. We believe from these investors may choose an appropriate ETF to satisfy the best index-based offerings individuals and financial advisors may utilize.ETFs are based on indexes tied to well-known index providers including Russell, S&P, Barclays, MSCI, Dow Jones and so forth. Also included are some so-called "enhanced" indexes that attempt to achieve better performance through more active management of the index. We feature a technical view of conditions from monthly chart views. Simplistically, we recommend longer-term investors stay on the right side of the 12 month simple moving average. When prices are above the moving average, stay long, and when below remain in cash or short. Some more interested in a fundamental approach may not care so much about technical issues preferring instead to buy when prices are perceived as low and sell for other reasons when high; but, this is not our approach. Premium members to the ETF Digest receive added signals when markets become extended such as DeMark triggers to exit overbought/oversold conditions. For traders and investors wishing to hedge, leveraged and inverse issues are available to utilize from ProShares and Direxion and where available these are noted. #10: PowerShares Dynamic Pharmaceuticals ETF (PJP) PJP follows the Dynamic Pharmaceuticals Intellidex Index which is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The fund was launched in June 2005. The expense ratio is .60%. AUM equal $244 million and average daily trading volume is 110K shares. As of early February 2012 the annual dividend yield was .62% and YTD return 5.32%. The one year return was 28.47% demonstrating the higher volatility with enhanced indexes. Data as of First Quarter 2012 PJP Top Ten Holdings
- Amgen Inc (AMGN): 5.24%
- Pfizer Inc (PFE): 5.23%
- Bristol-Myers Squibb Company (BMY): 5.21%
- Eli Lilly and Company (LLY): 5.20%
- Merck & Co Inc (MRK): 5.07%
- Abbott Laboratories (ABT): 4.81%
- Johnson & Johnson (JNJ): 4.77%
- Gilead Sciences Inc (GILD): 4.64%
- Salix Pharmaceuticals, Ltd. (SLXP): 3.31%
- Prestige Brands Holdings Inc (PBH): 3.26%
#9: iShares Dow Jones U.S. Healthcare Providers ETF (IHF)IHF tracks the Dow Jones U.S. Select Healthcare U.S. equity market. As such the index contains fewer holdings. The fund was launched in May 2006. The expense ratio is .48%. AUM equal $237 million with average daily trading volume over 88K shares. As of late early February 2012 the annual dividend yield was yield .13%% with YTD performance 6.19%. The one year return was 6.35% Data as of First Quarter 2012 IHF Top Ten Holdings
- UnitedHealth Group Inc (UNH): 12.88%
- Medco Health Solutions, Inc. (MHS): 7.47%
- Express Scripts (ESRX): 7.36%
- WellPoint Inc (WLP): 6.89%
- Aetna Inc (AET): 5.57%
- Humana (HUM): 5.18%
- Cigna Corp (CI): 4.74%
- Laboratory Corporation of America Holdings (LH): 3.82%
- Quest Diagnostics Inc (DGX): 3.70%
- DaVita Inc (DVA): 3.33%
- Jazz Pharmaceuticals PLC (JAZZ): 5.08%
- Hospira, Inc. (HSP): 4.93%
- Warner Chilcott PLC A (WCRX): 4.42%
- Endo Pharmaceutical Holdings, Inc. (ENDP): 4.39%
- ViroPharma, Inc. (VPHM): 4.35%
- Merck & Co Inc (MRK): 4.31%
- Forest Laboratories, Inc. (FRX): 4.30%
- Salix Pharmaceuticals, Ltd. (SLXP): 4.29%
- Allergan, Inc. (AGN): 4.23%
- Pfizer Inc (PFE): 4.18%
FXH follows the StrataQuant Healthcare index which is an "enhanced" index developed, maintained and sponsored by the NYSE Euronext or its affiliates which employs the AlphaDEX stock selection methodology to select Healthcare stocks from the Russell 1000 Index. The fund was launched in May 2007.
The expense ratio is .70%. AUM equal $550 million and average daily trading volume is 260K shares. As of early February 2012 the annual dividend yield was .12% and YTD return 7.74%. The one year return was 8.05%.Data as of First Quarter 2012 FXH Top Ten Holdings
- Amerigroup Corporation (AGP): 3.39%
- Tenet Healthcare Corp (THC): 2.78%
- Alexion Pharmaceuticals, Inc. (ALXN): 2.50%
- Biomarin Pharmaceutical, Inc. (BMRN): 2.41%
- Coventry Healthcare, Inc. (CVH): 2.36%
- Community Health Systems Inc (CYH): 2.35%
- Intuitive Surgical, Inc. (ISRG): 2.28%
- SXC Health Solutions Corporation (SXCI): 2.27%
- Perrigo Company (PRGO): 2.24%
- AmerisourceBergen Corp (ABC): 2.23%
- Johnson & Johnson (JNJ): 9.61%
- Pfizer Inc (PFE): 9.37%
- Merck & Co Inc (MRK): 8.30%
- Abbott Laboratories (ABT): 6.87%
- Bristol-Myers Squibb Company (BMY): 5.69%
- Eli Lilly and Company (LLY): 5.10%
- Allergan, Inc. (AGN): 4.54%
- Mylan Inc (MYL): 3.08%
- Forest Laboratories, Inc. (FRX): 2.97%
- Hospira, Inc. (HSP): 2.86%
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Check Out Our Best Services for Investors
Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.